Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20789
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antibodies, Monoclonal/adverse effects/*therapeutic use,Antirheumatic Agents/adverse effects/*therapeutic use,Female,Follow-Up Studies,Humans,Male,Middle Aged,Neoplasm Proteins/therapeutic use,Receptors, Tumor Necrosis Factor, Type II,Severity of Illness Index,Spondylitis, Ankylosing/*drug therapy,Treatment Outcome,Tumor Necrosis Factor Decoy Receptors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20789
ISSN: 0003-4967
Link: http://www.ncbi.nlm.nih.gov/pubmed/15564309
http://ard.bmj.com/content/64/6/940.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Nikas-2005-Infliximab treatment.pdf84.21 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons